Biotech

All Articles

Otsuka pays $800M for Jnana and also its own clinical-stage PKU drug

.Otsuka Pharmaceutical has gotten Boston-based Jnana Therapeutics for $800 million so the Japanese b...

FibroGen gives up 75% people team as property flunks 2 additional tests

.FibroGen is actually significantly restructuring its own service, giving up 75% of its USA staff as...

Tracon wane full weeks after injectable PD-L1 inhibitor stop working

.Tracon Pharmaceuticals has actually chosen to unwind operations weeks after an injectable immune ga...

Ideaya bags choice on Biocytogen bispecific ADC in $400M offer

.Ideaya Biosciences is betting $400 million in biobucks that a bispecific antibody-drug conjugate (A...

Takeda takes $140M reduction on neglected epilepsy drug, promotes FDA run

.Our team presently understand that Takeda is hoping to locate a course to the FDA for epilepsy medi...

VBI Vaccinations files for bankruptcy, seeks resource sale

.Immunology biotech VBI Vaccinations is actually diverting alarmingly close to the defining moment, ...

Celldex anti-cKIT antitoxin reduce colonies in yet another phase 2 research study

.It is actually hard to muscle in on a room as competitive as immunology, however Celldex Therapies ...

Boehringer offers up to $1.3 B for gate inhibitor biotech

.Boehringer Ingelheim is offering up to $1.3 billion for Nerio Therapeutics as well as a preclinical...

Ventyx's last resort for inflammatory med sides in Crohn's failing

.Ventyx Biosciences' Crohn's health condition medicine performed not assist patients achieve remissi...

Cognition's period 2 sparkle data stain Alzheimer's possibility

.Cognition Rehabs' stage 2 SHINE trial has taken a number of the gloss off the Alzheimer's disease m...